CPG 7909 Injection in Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00070629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Promune™ (CPG 7909 Injection) In Combination With Chemotherapy In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer, A Randomized, Multi-Center, Controlled, Phase 2 Study
Study identification
- NCT ID
- NCT00070629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 116 participants
Conditions and interventions
Conditions
Interventions
- CPG 7909 Drug
- Chemotherapy Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2003
- Primary completion
- Not listed
- Completion
- Jun 30, 2007
- Last update posted
- Feb 9, 2009
2003 – 2007
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Office of Ronald Yanagihara | Gilroy | California | 95020 | — |
| Kenmar Research Institute, LLC | Los Angeles | California | 90057 | — |
| Comprehensive Cancer Center of the Dessert | Palm Springs | California | 92262 | — |
| Florida Cancer Specialist | Fort Myers | Florida | 33901 | — |
| Indiana Hematology and Oncology Associates | Indianapolis | Indiana | 46202 | — |
| Medical Center Vincennes | Vincennes | Indiana | 47591 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Southeast Nebraska Hematology Oncology Consultants, PC | Lincoln | Nebraska | 68516 | — |
| VA New Jersey Health Care System | East Orange | New Jersey | 07018 | — |
| HemOnCare | Brooklyn | New York | 11212 | — |
| Cancer Care of Western North Carolina | Asheville | North Carolina | 28801 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Cancer Care Institute of Carolina | Aiken | South Carolina | 29801 | — |
| Charleston Hematology/Oncology, PA | Charleston | South Carolina | 29403 | — |
| The Family Cancer Center | Collierville | Tennessee | 38017 | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00070629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2009 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00070629 live on ClinicalTrials.gov.